新疆新姿源生物制药

Xinjiang Xinziyuan Biopharmaceutical is a specialized pharmaceutical company focused on the development and production of natural conjugated estrogens derived from pregnant mare urine (PMU). Headquartered in Urumqi, Xinjiang, the company utilizes the region's unique animal husbandry resources to produce high-quality hormone replacement therapies. Its product portfolio includes conjugated estrogen tablets and creams, which are primarily indicated for menopausal syndrome and the prevention of postmenopausal osteoporosis. The company is recognized as a key high-tech enterprise in China, maintaining a vertically integrated supply chain from raw material extraction to final pharmaceutical manufacturing. As the first domestic producer to break the international monopoly on PMU-derived estrogens, it plays a critical role in the Chinese women's health market.